z-logo
open-access-imgOpen Access
Raltitrexed in Patients With Dihydropyrimidine Dehydrogenase Deficiency
Author(s) -
Thyna Vu,
Carolyn Spry
Publication year - 2022
Publication title -
canadian journal of health technologies
Language(s) - English
Resource type - Journals
ISSN - 2563-6596
DOI - 10.51731/cjht.2022.493
Subject(s) - raltitrexed , medicine , adverse effect , nausea , vomiting , cardiotoxicity , placebo , oncology , chemotherapy , fluorouracil , thymidylate synthase , pathology , alternative medicine

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom